Work-Related Stress and Cancer: Recent Study Examines the Connection

Article

A recently-published Canadian study examined the possible correlation between work-related stress and cancer.

While nearly every single job has its stressful days, prolonged exposure to work-related stress can greatly impact an individual’s health and may increase their risk of developing certain kinds of cancers, according to a recent study conducted by researchers in Montreal, Canada.

Researchers from the University of Quebec and University of Montreal examined 3,103 men from 11 different workplaces who developed cancer. They were compared with 512 population controls.

The results found that employment in at least one stressful job increased the odds of lung, colon, bladder, rectal and stomach cancer. A duration-response trend was seen for cancers of the lung, colon, rectum, stomach and non-Hodgkin lymphoma.

“Prolonged exposure to perceived stress at work was associated with greater odds of cancer at five of 11 sites,” noted the authors.

Prolonged exposure, according to the authors, was anything over 15 years. There was no association between stress exposure for less than 15 years and cancer risk.

Plenty of studies have previously proven that stress can have detrimental health effects, but few, if any, studied work-related stress and its specific impact on odds of developing cancer.

To determine if there was a correlation, researchers gave participants questionnaires to fill out, which asked if they had frequent anxiety or depression or troubling sleeping at least once a week for six months. These were noted as the “psychological symptoms.” Participants were also asked about other factors such as their lifestyle and socioeconomic status. Then, the second part of the questionnaire specifically asked about their career, company and job description, as well as their perceived anxiety they experience from work.

Careers that had the highest amount of men who reported being stressed included: firefighters (40 percent); aerospace engineers (31 percent); and motor vehicle, rail transport mechanics and repairmen (28 percent).

As for socioeconomic status and stress, the study found that “men in the upper category of perceived stress duration (greater than 30 years) had the highest family income, the heaviest coffee and alcohol drinkers and reported psychological symptoms most often.”

The most common reasons cited for work-related stress included: high demand, time pressure, responsibilities, anxious temperament, financial insecurity, dangerous workplace, employee supervision, personal conflicts, difficult working conditions and traffic.

The authors said that more studies examining the correlation between work-related stress and cancer are crucial moving forward.

“While over-reporting of stress cannot be fully ruled out, these associations, if substantial, would bear public health significance. Prospective studies building on detailed stress assessment protocols considering all sources and changes over the career are necessary.”

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content